Large-scale testing (Phase 3)Study completedNCT00765830
What this trial is testing
Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
Who this might be right for
Diabetes Mellitus, Type 2Renal Insufficiency
Novartis 349